Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,211.50
-36.00 (-1.60%)
Apr 2, 2025, 3:30 PM JST
Rohto Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 507,855 | 676,888 | 631,946 | 421,488 | 336,849 | 337,648 | Upgrade
|
Market Cap Growth | 1.21% | 7.11% | 49.93% | 25.13% | -0.24% | 4.24% | Upgrade
|
Enterprise Value | 496,056 | 610,616 | 575,682 | 380,505 | 296,984 | 300,704 | Upgrade
|
Last Close Price | 2247.50 | 2928.17 | 2712.33 | 1792.85 | 1418.88 | 1410.26 | Upgrade
|
PE Ratio | 17.38 | 21.88 | 23.96 | 20.05 | 20.12 | 21.91 | Upgrade
|
Forward PE | 15.26 | 20.08 | 24.15 | 19.94 | 21.85 | 23.28 | Upgrade
|
PS Ratio | 1.73 | 2.50 | 2.65 | 2.11 | 1.86 | 1.79 | Upgrade
|
PB Ratio | 2.00 | 2.74 | 2.94 | 2.29 | 2.15 | 2.41 | Upgrade
|
P/TBV Ratio | 3.26 | 2.86 | 3.16 | 2.49 | 2.27 | 2.52 | Upgrade
|
P/FCF Ratio | 25.77 | 28.15 | 24.82 | 29.84 | 25.10 | Upgrade
| |
P/OCF Ratio | 19.77 | 20.43 | 15.47 | 16.84 | 17.73 | Upgrade
| |
PEG Ratio | 2.03 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | Upgrade
|
EV/Sales Ratio | 1.68 | 2.26 | 2.41 | 1.91 | 1.64 | 1.60 | Upgrade
|
EV/EBITDA Ratio | 10.80 | 12.50 | 13.93 | 10.61 | 10.38 | 10.08 | Upgrade
|
EV/EBIT Ratio | 13.56 | 15.20 | 17.17 | 13.50 | 13.58 | 13.14 | Upgrade
|
EV/FCF Ratio | 23.25 | 25.64 | 22.41 | 26.31 | 22.35 | Upgrade
| |
Debt / Equity Ratio | 0.14 | 0.04 | 0.05 | 0.12 | 0.05 | 0.05 | Upgrade
|
Debt / EBITDA Ratio | 0.84 | 0.21 | 0.28 | 0.60 | 0.28 | 0.24 | Upgrade
|
Debt / FCF Ratio | - | 0.40 | 0.52 | 1.26 | 0.72 | 0.54 | Upgrade
|
Asset Turnover | 0.79 | 0.83 | 0.82 | 0.80 | 0.82 | 0.91 | Upgrade
|
Inventory Turnover | 2.31 | 2.59 | 2.72 | 2.71 | 2.55 | 2.43 | Upgrade
|
Quick Ratio | 1.27 | 1.82 | 1.75 | 1.74 | 1.79 | 1.54 | Upgrade
|
Current Ratio | 1.93 | 2.47 | 2.37 | 2.30 | 2.36 | 2.10 | Upgrade
|
Return on Equity (ROE) | 11.49% | 13.59% | 13.25% | 12.42% | 11.31% | 11.23% | Upgrade
|
Return on Assets (ROA) | 6.17% | 7.66% | 7.17% | 7.04% | 6.20% | 6.87% | Upgrade
|
Return on Capital (ROIC) | 8.20% | 10.37% | 9.71% | 9.53% | 8.76% | 10.05% | Upgrade
|
Return on Capital Employed (ROCE) | 12.40% | 15.50% | 14.60% | 13.90% | 12.90% | 14.90% | Upgrade
|
Earnings Yield | 5.83% | 4.57% | 4.17% | 4.99% | 4.97% | 4.56% | Upgrade
|
FCF Yield | 3.88% | 3.55% | 4.03% | 3.35% | 3.98% | Upgrade
| |
Dividend Yield | 1.78% | 0.92% | 0.81% | 1.00% | 0.99% | 0.92% | Upgrade
|
Payout Ratio | 0.00% | 17.70% | 17.73% | 16.28% | 17.71% | 19.97% | Upgrade
|
Buyback Yield / Dilution | -0.00% | 0.00% | 0.00% | - | -0.01% | 0.00% | Upgrade
|
Total Shareholder Return | 1.78% | 0.92% | 0.81% | 1.00% | 0.98% | 0.92% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.